The Patent Finder

Terms ending in 2036

GlaxoSmithKline LLC

Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,441,787Neuromodulation Device
In force
 · High confidence
Galvani Bioelectronics LimitedIn forceHigh confidence
US 10,391,717Package and Heat Sealing Device
In force
 · High confidence
Haleon US Holdings LLCIn forceHigh confidence
US D920,093Package
In force
 · High confidence
Haleon UK IP LimitedIn forceHigh confidence
US 12,187,789Biopharmaceutical Compositions
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 12,187,790Biopharmaceutical Compositions
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 12,187,791Biopharmaceutical Compositions
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 10,960,032Use of Akkermansia Muciniphila for Treating Inflammatory Conditions
In force
 · Low confidence
Enterobiome Inc.In forceLow confidence
7 of 7 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited